Investors
- Home
- Investors
- Corporate Governance
- Corporate Governance Officer
Event News
Financial Information
Shareholders
Corporate Governance
Gluphor 50/850 mg Film-Coated Tablets
Gluphor 50/500 mg Film-Coated Tablets
Gaty film-coated tablet 600mg
Ferich Forte Capsules
Fendown F.C. Tablets 160mg
Doros CORS Tablets 4mg
Donvex CORS Tablets 9 mg
Donvex CORS Tablets 6 mg
Donvex CORS Tablets 3 mg
DonGlu Tablets 4mg
ZOLOTIN FILM COATED TABLETS 20MG
Zoliton Tablets 10/20mg
Zoliton Tablets 10/10mg
Zerocal Capsules 120mg
Veinlax F.C. Tablets 500mg
Uridin F.C. Tablets 2mg
Disfect F.C. Tablets 250mg
Thamic Otic Solution 0.3%
Tamokas Prolonged Release Tablets 0.4mg
Dephos F.C. Tablets 400mg
Tamokas D Tablets 0.4mg
Tamokas D Tablets 0.2mg
Taglu F.C. Tablets 100mg
Standfil Tablets 5mg
Standfil Tablets 20mg
DAMPURINE TABLETS 25MG
Sordur Controlled-Release Tablets 60mg
Rofew I.V. infusion solution 200 mg/ml
Comide Extended Release Tablets 36mg
Relung F.C. Tablets 20mg
Comide Extended Release Tablets 27mg
Pitanxo F.C. Tablets 4mg
Comide Extended Release Tablets 18mg
Pinvio Tablets 12.5mg
Ozyn Soft Gelatin Capsules 20mg
Ozyn Soft Gelatin Capsules 10mg
Cinaca F.C. Tablets 25mg
Norxicam Rapid F.C. Tablets 8mg
Chalian Powder
Norepine Injection
Nophos powder for oral suspension
Carvio Tablets 6.25mg
Nophos F.C. Tablet 800mg
Carvio Tablet 25mg
NILASEN TABLETS 24MG
NILASEN TABLETS 16MG
Niferos OROS 30mg
Mifiry Injection
BUSACON TABLETS 0.125MG
Boseten Soft Capsules 150mg
Boseten Soft Capsules 100mg
MELSTATIN TABLETS 20MG
Bojum Intravenous Injection 0.25g, 0.5g
Melstatin tablet 40mg
Ariple Tablets 20mg
Melosa 5/40 mg F.C. Tablets
Ariple Tablets 10mg
Limus F.C. Tablets 25 mg
Arika Tablets 15mg
Lecadopa 25/100 Tablets
Kuzem Powder
Anxotos Tablets 30mg
Kludone MR Tablets 60mg
Anxotos Tablets 15 mg
Anxomine Tablet 2mg
HYTONIN TABLETS 10MG
Anxolipo F.C. Tablets 40mg
Anxolipo F.C. Tablet 10 mg
Anxolightor F.C. Tablets 20 mg
Anxokast F.C. Tablets 10mg
Anxokast chewable tablets 4mg
Anxokast Chewable Tablet 5mg
Anfero Film-Coated Tablets 360 mg
Corporate Governance Officer
In order to implement corporate governance and promote the effective function of the Board, the Company has approved the appointment of Mr. Aderson Lee as Corporate Governance Officer of the Company on December 29, 2023 by the Board. The Corporate Governance Officer is the highest executive in charge of corporate governance related matters. The corporate governance personnel responsible for the corporate governance business of each relevant unit are responsible for various matters of corporate governance. The Company's Corporate Governance Officer has more than 3 years of working experience at public offering companies engaged in audit, financial, accounting and stock affairs management.
It is required that the corporate governance affairs mentioned in the preceding paragraph include at least the following items:
- Handling matters related to board of directors and shareholders' meetings in accordance with the law.
- Preparing minutes for board of directors and shareholders' meetings.
- Assisting directors and supervisors in their appointment and continuing education.
- Providing necessary information for directors and supervisors to carry out their duties.
- Assisting directors and supervisors in compliance with laws and regulations.
- Reporting to the board of directors on the compliance of independent directors with relevant laws and regulations during the nomination, appointment, and tenure process.
- Handling matters related to changes in the board of directors.
- Other matters stipulated in the company's bylaws or contracts.
Continuing Education Training of Corporate Governance Officer:
| Training Date | Organizer | Course Name | Training Hour |
|---|---|---|---|
| 2024/4/12 | Taiwan Corporate Governance Association | Practical analysis and key issues of corporate overseas investment and mergers and acquisitions | 3 |
| 2024/8/1 | Corporate Operating and Sustainable Development Association | Analysis of Regulations and Practical Disputes Related to the Board of Directors | 3 |
| 2024/8/15 | Accounting Research and Development Foundation | Strengthening Internal Control Functions and Board Mechanisms with Analysis of Fraud Cases | 6 |
| 2024/9/4 | Corporate Operating and Sustainable Development Association | Corporate Governance and Practical Operations of Independent Directors | 3 |
| 2024/9/10 | Taipei Exchange (TPEx) | Seminar on Insider Shareholding for Emerging and OTC-listed Companies | 3 |
| 2024/10/17 | Corporate Operating and Sustainable Development Association | Legal Regulations and Risk Liabilities for Directors, Supervisors, and Insiders under Corporate Governance | 3 |